By IDSE News Staff
Bionpharma issued a voluntary nationwide recall of atovaquone oral suspension, 750 mg/mL because of bacterial contamination.
Atovaquone is a quinone antimicrobial drug indicated to prevent Pneumocystis jirovecii pneumonia in adults and adolescents 13 years of age and older.
A single batch (2310083) of atovaquone oral suspension, 750 mg/mL was being recalled. The affected batch of the product was manufactured at CoreRx Inc. and shipped nationwide to customers between